0.3987

0.00% 0.00

Bionexus Gene Lab Corp (BGLC)

Overview News Price History Discussions Forecast

Bionexus Gene Lab Corp stock is traded at $0.3987, with a volume of 41,882. It is up +0.00% in the last 24 hours and up +9.20% over the past month. BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Previous Close:

$0.3987

Open:

$0.379

24h Volume:

41,882

Relative Volume:

0.01

Market Cap:

$7.16M

Revenue:

$9.26M

Net Income/Loss:

$-941.60K

P/E Ratio:

-5.5375

EPS:

-0.072

Net Cash Flow:

$-2.65M

1W Performance:

-2.16%

1M Performance:

+9.20%

6M Performance:

-8.56%

1Y Performance:

-7.28%

1-Day Range:

$0.379

$0.4043

1-Week Range:

$0.379

$0.419

52-Week Range:

$0.2105

$3.39

Bionexus Gene Lab Corp Stock (BGLC) Company Profile

Name

Bionexus Gene Lab Corp

Sector

Basic Materials (268)

Industry

Specialty Chemicals (64)

Phone

1-307-241-6898

Address

10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BGLC's Discussions on Twitter

Compare BGLC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BGLC BioNexus Gene Lab Corp Common stock	0.343	201.51M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	0.1891	443.17M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	20.70	372.90M	0	0	0	0.00
SHMD Schmid Group N V	2.21	89.14M	0	0	0	0.00
JUNE Dhandho Junoon Etf	4.03	48.39M	0	0	0	0.00
USVM USAA MSCI USA Small Cap Value M	86.36	0	0	0	0	0.00

Bionexus Gene Lab Corp Stock (BGLC) Latest News

Jan 21, 2025

12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Jan 21, 2025

Jan 15, 2025

Short Interest in BioNexus Gene Lab Corp. (NASDAQ:BGLC) Increases By 79.6% - Defense World

Jan 15, 2025

Jan 04, 2025

BioNexus Gene Lab Receives Temporary Exception from Nasdaq Bid Price RuleOn December 27, 2024, BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced in a recent 8-K filing that it has been granted a temporary exception by the Nasdaq Hearings Pa - Defense World

Jan 04, 2025

IQVIA Holdings Inc. (NYSE:IQV) Receives $255.82 Consensus PT from Analysts - Defense World

Jan 04, 2025

Silence Therapeutics Transitioning to U.S. Domestic Issuer Status - Defense World

Jan 04, 2025

Jan 02, 2025

Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading - Business Upturn

Jan 02, 2025

Dec 28, 2024

Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 148.2% - Defense World

Dec 28, 2024

Dec 27, 2024

BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World

Dec 27, 2024

Dec 20, 2024

BioNexus Gene Lab stock hits 52-week low at $0.22 - Investing.com

Dec 20, 2024

Dec 17, 2024

Critical Survey: BioNexus Gene Lab (NASDAQ:BGLC) versus MDxHealth (NASDAQ:MDXH) - Defense World

Dec 17, 2024

Dec 06, 2024

BioNexus Gene Lab Leads Our Top 3 US Penny Stocks - Simply Wall St

Dec 06, 2024

Dec 02, 2024

Stock market news: Senti Biosciences surge by 428.24% while Mondee Holdings plunged by 46.49% during mid day trading - Business Upturn

Dec 02, 2024

Nov 29, 2024

Thinking about buying stock in BioNexus Gene Lab, Gladstone Inve - GuruFocus.com

Nov 29, 2024

Nov 26, 2024

BGLC stock touches 52-week low at $0.28 amid sharp annual decline By Investing.com - Investing.com South Africa

Nov 26, 2024

BGLC stock touches 52-week low at $0.28 amid sharp annual decline - Investing.com Nigeria

Nov 26, 2024

Nov 16, 2024

BioNexus Gene Lab Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 16, 2024

Nov 15, 2024